News Posts List
Pfizer Backs Out Of Bidding For Cancer Drug Maker Onyx As Shares Soar Amid Sale Process
07/20/2013
Pfizer opted out of bidding for Onyx this week, placing Amgen in the lead to buy the cancer-drug maker.
Robotic ultrasound developed to screen for kidney cancers
07/17/2013
Medical technologists have carried out a study that demonstrates the benefits that robotic ultrasound techniques can offer in the treatment of kidney cancers.
Past colon cancer tied to future cancer risks
07/16/2013
People who have had colon cancer are 15 percent more likely to be diagnosed with another cancer than those with no history of the disease, a new study suggests.
Just Released: "Transitional Cell Carcinoma"
07/16/2013
Global Markets Direct's, 'Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline.
Kidney Cancer Association Partners with Lotsa Helping Hands
07/15/2013
New website supports caregivers.
PSU 2013 Lift For Life Raises $133,000
07/15/2013
The 11th Annual Penn State Uplifting Athletes "Lift For Life" was a tremendous success on Friday, raising the 2013 total to a record total in excess of $130,000 to benefit the Kidney Cancer Association.
Penn State center hopes to give lift to the Nittany Lions' offensive line
07/13/2013
Senior Ty Howle has shaggy brown hair and an easy-going personality that allows him to quickly transition between subjects like football -- he likely will be Penn State's starting center this fall -- and everything else.
Renal Cells Express Different Forms of Vimentin
07/13/2013
Osmotic stress has been shown to regulate cytoskeletal protein expression.
Highlights from the 5th BHD and Second HLRCC symposium
07/13/2013
Two weeks ago, more than 100 researchers, clinicians and patients attended the Fifth BHD and Second HLRCC Symposium in Paris, France. The conference was held over two days in the beautiful École du Louvre, which was founded in 1882 to study the collections belonging to the adjacent Musée du Louvre art gallery.
EMA Lifts Conditional Status For GSK's Votrient® (Pazopanib) And Grants Full Approval
07/12/2013
GlaxoSmithKline (GSK) has announced that the European Medicines Agency (EMA) has agreed to remove the conditional status of the marketing authorisation for Votrient (pazopanib)...
News Feed